Vantage Consulting Group’s Insulet PODD Stock Holding History

Vantage Consulting Group’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5	Closed	-$1K	–	1181
2020 Q4	$1K	Buy	+5	New	+$1.24K	﹤0.01%	1789

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vantage Consulting Group's PODD Position: Q1 2021 in Review

Vantage Consulting Group sold out of Insulet (PODD) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

Vantage Consulting Group first reported a position in PODD in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 452 funds tracked by Wall St. Rank hold PODD as of Q1 2021.

Vantage Consulting Group reported no remaining Insulet position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 5 Insulet shares in Q1 2021, an estimated $1K.
Vantage Consulting Group first reported a position in Insulet in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Insulet position peaked at $1K in Q4 2020.
452 funds tracked by Wall St. Rank held Insulet as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.